Understanding the Biosecure Act: Implications for the Pharmaceutical Industry

  The Biosecure Act is a significant legislative proposal aimed at reshaping the pharmaceutical supply chain landscape, particularly concerning the s...

July 21, 2024 | Sunday | Reports
Johnson & Johnson Announces Positive Results from Phase 3 Vivacity-MG Study of Nipocalimab in Patients with Generalized Myasthenia Gravis

Johnson & Johnson  announced positive results from the nipocalimab Phase 3 Vivacity-MG study in patients with generalized myasthenia gravis (gMG...

July 01, 2024 | Monday | Reports
UCB Presents Promising Data on Certolizumab Pegol for Pregnant Women and High RF RA Patients at EULAR 2024

  Pharmacokinetic data from the CHERISH study suggest that pregnant women treated with certolizumab pegol can maintain their do...

June 17, 2024 | Monday | News
Breakthrough Study Links Aging Blood Stem Cells to Increased Inflammatory Diseases

As humans age, hematopoietic stem cells—the immature precursor cells that give rise to all blood and immune cells—accumulate mutations. Some ...

June 12, 2024 | Wednesday | Reports
Global Cancer Cases Set to Surge to 32 Million Annually by 2050, with Dramatic Increases in Low-Income Countries

Cancer incidence is expected to rise significantly through 2050, particularly in lower-income countries, to 32 million new cases annually – a pot...

June 11, 2024 | Tuesday | Reports
A Strategic Vision for Global Health: Investing in a Safer Future

Investing in Global Health for a Safer Future World Health Organization's (WHO) "All for Health, Health for All: Investment Case 2025–2028...

June 10, 2024 | Monday | News
Pfizer's ADCETRIS Combination Therapy Shows Remarkable 37% Reduction in Risk of Death in Phase 3 ECHELON-3 Study

Detailed data from Phase 3 ECHELON-3 study demonstrate investigational ADCETRIS regimen reduced risk of death by 37 percent compared to chemotherapy ...

June 03, 2024 | Monday | News
Hepatitis: The silent killer

May is Hepatitis Awareness Month, the perfect time for individuals to talk to their health care providers about hepatitis vaccinations. Hepatitis is an inf...

May 20, 2024 | Monday | Reports
AlphaFold 3 Unleashed: Because Who Needs Scientists Anyway?

Google DeepMind and Isomorphic Labs have unveiled AlphaFold 3, a groundbreaking AI model poised to rewrite the rulebook on molecular biology and redefine t...

May 10, 2024 | Friday | News
New Dietary Guidelines Released to Combat Nutritional Challenges in India

The National Institute of Nutrition (NIN), under the Indian Council of Medical Research (ICMR), has released updated "Dietary Guide...

May 10, 2024 | Friday | Reports
Industry Titans Illuminate Path to Pharmaceutical Innovation at INTERPHEX 2024

Industry pioneers Maria Batalha, Kevin J. Bittorf, Matthew Mollan, and John Nadzam took center stage at INTERPHEX 2024 to share their expertise and insight...

April 17, 2024 | Wednesday | Expert Opinion
INTERPHEX 2024 Sheds Light on Cutting-Edge Solutions: Leveraging AI for Fraud Detection in Pharma

Conference Session Recap: Leveraging AI for Fraud Detection in Pharma - Insights from INTERPHEX 2024  Attendees at INTERPHEX 2024 were treated to a t...

April 16, 2024 | Tuesday | News
Advancements in AI Revolutionize 3D Printed Tablet Formulation Design: Insights from Metin Celik's Presentation

Today, attendees at INTERPHEX 2024 were treated to an illuminating presentation by Metin Celiak, delving into the transformative potential of Artificial In...

April 16, 2024 | Tuesday | News
Breakthrough Cardiac Study Reveals Long-Term Impact on Post-Transplant Survival: A 2-Year Clinical Investigation Advancing Heart Preservation

Paragonix Technologies, Inc., a pioneer in organ transplant technologies and services, announces the annual release of the latest GUARDIAN-Heart Clinical R...

April 14, 2024 | Sunday | Reports

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close